Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Tang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Cytogenetics , 2012 - 2013
University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2010 - 2012
UMass Chan Medical SchoolResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Hunan Medical UniversityClass of 1989
Certifications & Licensure
TX State Medical License 2012 - 2028
CT State Medical License 2010 - 2012
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics- American Board of Pathology Hematopathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2014-2015
Publications & Presentations
PubMed
- Deletion 11q, monosomy 13, and deletion 13q in noncomplex karyotype acute myeloid leukemia.Adelaide J Kwon, Miguel D Cantu, Guilin Tang, Sa A Wang, Sharon K Germans
Blood Neoplasia. 2026-08-01 - Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL.Sankalp Arora, Hagop Kantarjian, Koji Sasaki, Nitin Jain, Zhouxuan Li
American Journal of Hematology. 2026-08-01 - Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell tran...Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour
British Journal of Haematology. 2026-07-06
Journal Articles
- Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter StudyGuilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature
- Original Contribution IgM Plasma Cell Myeloma in the Era of Novel Therapy: A Clinicopathologic Study of 17 Cases☆Shaoying Li, Pei Lin, L Jeffrey Medeiros, Guilin Tang, ScienceDirect
- High-Grade B-cell Lymphomas with TdT Expression: A Diagnostic and Classification DilemmaChi Young Ok, L Jeffrey Medeiros, Sergej Konoplev, Nitin Jain, Elias Jabbour, Guilin Tang, Nature
Abstracts/Posters
- Non-Bcl2 Mutations Are Predominant in Patients (pts) with Venetoclax Resistant Mantle Cell Lymphoma (MCL) _ Response and Clinical Outcomes in Ultra-Refractory MCLGuilin Tang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A (MLL) RearrangementGuilin Tang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma _ Cohort Study of 369 PatientsGuilin Tang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AMLMarch 13th, 2025
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
